Drug meant for treating infertility in women: Ramdev’s trust

'The packaging does not bear writings suggesting that the drug ensures birth of a male child.'

Yoga guru Ramdev. File photo: Ashoke Chakrabarty.

Ramdev’s Patanjali Yogpeeth Trust on Sunday sought to clarify the controversy over ‘Putrajeevak Beej’ medicine manufactured by the yoga guru-owned Divya Pharmacy, saying that the drug was meant for dealing with the problem of infertility in women and termed as “false and misleading” the notion that it promises a male child.

The trust in a statement said, “The idea that the medicine helps determine the sex of a child is false and misleading since it is consumed by women and as per science, male chromosomes determine the sex of a child.”

The trust argued that the packaging of the medicine does not bear writings suggesting that the drug ensures birth of a male child.

“The packaging mentions that the ‘Putrajeevak Beej’ helps treating infertility and other related problems in women,” the trust said in the statement.